Australia-based Firebrick Pharma has secured firm commitments from strategic investors for approximately $732k, through ...
Japan-based Ono Pharmaceutical has entered into an exclusive license agreement with Biohaven, together with its wholly o...
South Korea-based Lunit, a leading provider of AI for cancer diagnostics and precision oncology, has announced a strateg...
Taiwan-based Foresee Pharmaceuticals has been notified by its licensing partner, Changchun GeneScience Pharmaceutical (G...
Japan-based Shimadzu Corporation has started the development and validation of a mass spectrometry (MS) solution for cor...
US-based Danaher Corporation has announced plans to launch its first AI-powered autonomous lab, designed to help researc...
South Korea-based LOTTE Biologics, a contract development and manufacturing (CDMO) organisation, and Alvotech, a global ...
GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a leading US-based CMO for PET radiopha...
If the opening day of BioJapan 2026 diagnosed the gap between Japanese science and global deals, the second day at PACIF...
China's XtalPi Holdings, an AI and robotics-driven drug and materials discovery company, has debuted Kodexia™, the...
South Korea-based GC Cell, a leader in the cell and gene therapy (CGT) sector within the biopharmaceutical industry, and...
Japan-based Shionogi & Co. is entering into an agreement to acquire IntraBio Inc, a biopharmaceutical company develo...
AstraZeneca has announced the opening of its newest global strategic research and development (R&D) centre, in Kenda...
Yokohama, 7 October 2026 | BioJapan 2026, Regenerative Medicine JAPAN and healthTECH JAPAN, PACIFICO Yokoham...
Merck, known as MSD outside of the United States and Canada, and China-based startup SciBrunch Therapeutics have entered...
China-based startup Abogen Biosciences, a clinical-stage biotechnology group pioneering RNA innovation, has entered...
Taiwan-based Energenesis Biomedical has signed a Memorandum of Understanding (MoU) with Yoo Young Pharm (YYO), a South K...
SK pharmteco, a subsidiary of SK Inc., the strategic investment company for SK Group, South Korea’s second-la...
Qiagen has announced new artificial intelligence (AI) capabilities to help researchers analyse complex biological and ge...
Japanese startup Celaid Therapeutics Inc. has announced the completion of the second close of its Series B financing rou...
Australia-based CSL and Swiss firm Alentis Therapeutics have entered into an exclusive global collaboration agreement to...
Bayer has announced plans to invest $2.2 billion in a new pharmaceutical manufacturing site in New Albany, Ohio, US. Bui...
China-based Hengrui Pharma has entered into a license agreement with Novo Nordisk for HRS-1596, a phase I-ready glucagon...
Reprocell Inc. has entered into a basic agreement with Toho Holdings toward a partnership concerning the domestic distri...
The Ministry of Health and Welfare, South Korea government, has announced that it will open K-Beauty experience and reta...
